According to Gram Research analysis, about 1 in 10 women (10.2%) with a positive HPV test did not attend their required follow-up appointment within 6 months in a Dutch study of over 5,000 screening participants. Researchers found that women who had not been regularly screened before were significantly less likely to show up for follow-up, but surprisingly, lifestyle factors like diet, exercise, and smoking did not predict attendance. The findings suggest that clear communication from doctors about why follow-up matters may be more effective than targeting specific groups of women.

When women test positive for a virus that can cause cervical cancer, they need to follow up with their doctor for additional testing. A new study from the Netherlands looked at why some women don’t show up for this important follow-up appointment. Researchers found that most lifestyle habits and background factors don’t predict who will skip the appointment. Instead, they discovered that women who hadn’t been screened regularly in the past were more likely to miss their follow-up visit. The findings suggest that how doctors communicate test results to patients might be more important than targeting specific groups of women.

Key Statistics

A cohort study of Dutch women in cervical cancer screening found that 10.2% of women with a positive hrHPV self-sample did not attend their required follow-up cytology triage appointment within 6 months between 2017 and 2024.

According to research reviewed by Gram, inadequate prior screening history was the only factor significantly associated with lower odds of attending follow-up cytology triage after a positive HPV test, while lifestyle factors like smoking, diet, and exercise showed no meaningful associations.

A 2026 study of cervical cancer screening in the Netherlands found that sociodemographic factors including education level, income, and marital status did not predict whether women would attend follow-up appointments after testing positive for hrHPV.

The Quick Take

  • What they studied: Whether women who test positive for a cancer-causing virus (hrHPV) actually show up for their required follow-up doctor visit, and what factors predict who will or won’t attend
  • Who participated: Women in the Netherlands who participated in cervical cancer screening and used self-sampling tests between 2017 and 2024. The study included women of various ages, education levels, income levels, and health habits
  • Key finding: About 1 in 10 women (10.2%) with a positive HPV test did not attend their follow-up appointment within 6 months. Women who had not been regularly screened before were significantly less likely to show up for follow-up testing
  • What it means for you: If you test positive for HPV, attending your follow-up appointment is crucial for catching any problems early. The study suggests doctors should focus on clearly explaining why follow-up matters rather than assuming certain groups of women need extra reminders

The Research Details

Researchers used data from a large group of Dutch women called the Lifelines cohort who participated in cervical cancer screening programs from 2017 to 2024. They looked at women who used self-sampling tests (tests women can do at home) and tested positive for hrHPV, a virus linked to cervical cancer. The main question was simple: did these women show up for their required follow-up appointment at their doctor’s office within 6 months?

The researchers collected detailed information about each woman’s background and lifestyle, including education level, income, marital status, smoking habits, diet, exercise, sleep, and previous screening history. They then used statistical analysis to see which factors predicted whether a woman would attend her follow-up appointment. They also looked separately at different age groups to see if the patterns were different for younger versus older women.

This type of study is valuable because it uses real-world data from an actual screening program rather than a controlled experiment. This means the results reflect what actually happens when women receive positive test results and are asked to follow up with their doctors.

Understanding why women skip follow-up appointments is critical because missing this step defeats the purpose of screening. If a woman tests positive but never gets the follow-up testing, doctors can’t catch early signs of cancer. The study’s approach of examining many different factors helps identify the real barriers to attendance, which can guide better solutions

This study used data from a well-established research cohort with detailed health and lifestyle information on participants. The large sample size and long study period (2017-2024) provide reliable results. However, the study is observational, meaning it can show associations but not prove that one factor causes another. The researchers were careful to measure many different factors that might influence attendance

What the Results Show

Among women who tested positive for hrHPV, 89.8% attended their follow-up cytology triage appointment within 6 months, while 10.2% did not attend. This non-attendance rate is important because it means roughly 1 in 10 women with a positive result are not getting the follow-up testing they need.

When researchers looked at lifestyle and background factors like education, income, smoking, diet, exercise, and sleep habits, they found almost none of these predicted whether a woman would attend her follow-up appointment. This was surprising because previous research suggested these factors influence screening participation. The lack of association held true across different age groups, meaning younger and older women showed similar patterns.

The one factor that did matter was prior screening history. Women who had not been regularly screened before testing positive were significantly less likely to attend their follow-up appointment. This suggests that women who are already engaged with screening programs are more likely to complete the follow-up process, while women new to screening may need extra support.

The researchers found no meaningful differences between age groups in terms of which factors predicted follow-up attendance. This indicates that strategies to improve attendance should focus on all women, not just specific age groups.

The study examined many lifestyle factors including smoking status, alcohol consumption, diet quality, body mass index, physical activity levels, television viewing time, and sleep duration. None of these showed meaningful associations with follow-up attendance. Similarly, sociodemographic factors like marital status, education level, and income did not predict attendance. Reproductive factors including contraceptive use, number of children, and age at first childbirth also showed no significant associations

Previous research on cervical cancer screening participation has identified sociodemographic and lifestyle factors as important barriers to initial screening. This study suggests that once women have tested positive and need follow-up, these same factors become less important. This is an important distinction because it means the barriers to initial screening may be different from the barriers to completing follow-up after a positive result. The finding aligns with other research showing that communication and clarity about test results can be more influential than demographic characteristics

The study examined women in the Netherlands who participated in a specific screening program, so results may not apply to other countries with different healthcare systems or screening approaches. The researchers could not determine why women didn’t attend, only that they didn’t show up. The study is observational, so it cannot prove that inadequate prior screening causes lower follow-up attendance, only that these factors are associated. Additionally, the study did not examine factors like access to transportation, childcare, or work schedules, which might influence attendance

The Bottom Line

If you test positive for hrHPV on a self-sample test, schedule your follow-up appointment with your doctor as soon as possible and attend within 6 months. This follow-up is essential for determining whether you need further treatment. Healthcare providers should focus on clearly explaining why follow-up matters and making the process as easy as possible, rather than assuming certain groups of women need special reminders. Strong evidence supports this approach based on the study findings

This research matters for all women who use self-sampling HPV tests as part of cervical cancer screening. It’s particularly relevant for women who haven’t been regularly screened before, as they appear to be at higher risk of missing follow-up appointments. Healthcare providers and public health officials should use these findings to improve how they communicate test results and encourage follow-up attendance

Follow-up appointments should be completed within 6 months of receiving a positive HPV test result. The sooner you schedule and attend this appointment, the sooner you’ll have clarity about whether further action is needed. Don’t delay, as waiting longer increases the risk of missing the recommended timeframe

Frequently Asked Questions

What should I do if I test positive for HPV on a self-sample test?

Schedule a follow-up appointment with your doctor immediately to get cytology triage testing, which cannot be done on self-samples. Research shows 89.8% of women who attend this follow-up get timely results, so attending within 6 months is critical for catching any problems early.

Why do some women skip their follow-up appointment after an HPV-positive test?

A study of 5,000+ Dutch women found that women with inadequate prior screening history were less likely to attend follow-up, but lifestyle factors like smoking and diet didn’t predict attendance. The research suggests better communication about why follow-up matters may help more than targeting specific groups.

Does my age affect whether I should get follow-up testing after a positive HPV result?

No. Research shows that age-related differences in follow-up attendance were minimal, meaning women of all ages should prioritize attending their follow-up appointment within 6 months of a positive HPV test result.

What factors predict whether someone will attend their HPV follow-up appointment?

A 2026 cohort study found that prior screening history was the main predictor, with regularly screened women more likely to attend follow-up. Surprisingly, education, income, smoking, diet, exercise, and other lifestyle factors showed no meaningful association with attendance.

Want to Apply This Research?

  • Set a reminder in your health app to schedule your follow-up cytology appointment within 2 weeks of receiving an hrHPV-positive result, and track the date you actually attend the appointment
  • If you receive a positive HPV test result, immediately add a task to your app to call your doctor’s office and schedule the follow-up visit. Mark the appointment date clearly and set multiple reminders as the date approaches
  • Use your app to log all cervical cancer screening activities including self-sample tests, positive results, follow-up appointments, and any subsequent testing or treatment. This creates a complete screening history that you can share with your healthcare provider

This article summarizes research findings and should not replace medical advice from your healthcare provider. If you have tested positive for hrHPV or have questions about cervical cancer screening, consult your doctor or gynecologist. The findings apply specifically to women in Dutch screening programs and may not generalize to all populations or healthcare systems. Always follow your healthcare provider’s recommendations regarding screening and follow-up testing.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Factors associated with cytology triage attendance after a hrHPV-positive self-sample and age-related differences: The lifelines cohort. , Journal of medical screening (2026). PubMed 42885758 | DOI
Topics
HPV testing cervical cancer screening follow-up appointments self-sampling cytology triage screening participation women's health cancer prevention